Brief: Collegium Provides 2023 Financial Guidance

Collegium Pharmaceutical

04/01/2023 13:18

Jan 4 (Reuters) - Collegium Pharmaceutical Inc  COLL.O :
    * COLLEGIUM PROVIDES 2023 FINANCIAL GUIDANCE
    * COLLEGIUM PHARMACEUTICAL INC - 2023 PRODUCT REVENUES, NET
ARE
EXPECTED IN RANGE OF $565.0 MILLION TO $580.0 MILLION
    * COLLEGIUM PHARMACEUTICAL INC - 2023 PRODUCT REVENUES, NET
EXPECTED IN RANGE OF $565.0 MILLION TO $580.0 MILLION
    * COLLEGIUM PHARMACEUTICAL INC - 2023 ADJUSTED EBITDA
(EXCLUDING
STOCK-BASED COMPENSATION) IS EXPECTED IN RANGE OF $355.0 MILLION
TO $370.0 MILLION
    * COLLEGIUM PHARMACEUTICAL INC - $100 MILLION SHARE
REPURCHASE
PROGRAM AUTHORIZED BY BOARD OF DIRECTORS

Source text for Eikon:  ID:nGNX9dMWFr 
Further company coverage:  COLL.O 
 ((Reuters.Briefs@thomsonreuters.com;))